AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Monarch Casino & Resort
MCRI
$2.2B
| $966K | ﹤0.01% |
17,200
+19
| +0.1% | +$1.16K |
|
2302
Nabors Industries
NBR
$1.27B
| $965K | ﹤0.01% |
9,513
+27
| +0.3% | +$3.31K |
|
2303
FLEX LNG
FLNG
$1.69B
| $963K | ﹤0.01% |
30,402
+2,302
| +8% | +$72.9K |
|
2304
Tidewater
TDW
$3.73B
| $961K | ﹤0.01% |
44,300
-4,200
| -9% | -$89.5K |
|
2305
Fulgent Genetics
FLGT
$470M
| $960K | ﹤0.01% |
25,185
+106
| +0.4% | +$5.31K |
|
2306
The Greenbrier Companies
GBX
$1.52B
| $960K | ﹤0.01% |
39,575
-2,827
| -7% | -$85.2K |
|
|
DCT
2307
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $960K | ﹤0.01% |
81,037
+85
| +0.1% | +$1.12K |
|
2308
Utz Brands
UTZ
$1.25B
| $956K | ﹤0.01% |
63,300
+1,600
| +3% | +$25.9K |
|
|
INFN
2309
DELISTED
Infinera Corporation Common Stock
INFN
| $952K | ﹤0.01% |
196,768
-964
| -0.5% | -$5.28K |
|
|
STKL
2310
DELISTED
SunOpta
STKL
| $950K | ﹤0.01% |
104,400
+8,200
| +9% | +$77.8K |
|
|
LPRO
2311
Open Lending Corp
LPRO
| $947K | ﹤0.01% |
117,800
-10,000
| -8% | -$101K |
|
2312
Remitly
RELY
$4.79B
| $945K | ﹤0.01% |
85,000
| – | – |
|
|
XIFR
2313
XPLR Infrastructure LP
XIFR
$1.12B
| $944K | ﹤0.01% |
13,059
-2,820
| -18% | -$226K |
|
2314
Five Star Bancorp
FSBC
$1.14B
| $943K | ﹤0.01% |
33,254
+700
| +2% | +$18.4K |
|
2315
Adaptive Biotechnologies
ADPT
$3.59B
| $941K | ﹤0.01% |
132,196
-6,625
| -5% | -$62.4K |
|
2316
Select Water Solutions
WTTR
$2.3B
| $940K | ﹤0.01% |
134,822
+42,636
| +46% | +$296K |
|
|
HA
2317
DELISTED
Hawaiian Holdings, Inc.
HA
| $939K | ﹤0.01% |
71,433
+75
| +0.1% | +$1.15K |
|
|
AGNT
2318
AGNT Inc
AGNT
$666M
| $938K | ﹤0.01% |
83,653
| – | – |
|
2319
Allogene Therapeutics
ALLO
$649M
| $934K | ﹤0.01% |
86,519
-542,988
| -86% | -$7.38M |
|
|
MNTV
2320
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $934K | ﹤0.01% |
160,674
-18
| -0% | -$140 |
|
2321
Columbia Financial
CLBK
$1.12B
| $932K | ﹤0.01% |
44,100
-2,200
| -5% | -$47.5K |
|
2322
Cerence
CRNC
$385M
| $930K | ﹤0.01% |
59,054
+38
| +0.1% | +$853 |
|
2323
Standard Motor Products
SMP
$851M
| $930K | ﹤0.01% |
28,602
-30
| -0.1% | -$1.19K |
|
2324
TG Therapeutics
TGTX
$7.96B
| $929K | ﹤0.01% |
156,900
| – | – |
|
2325
Yext
YEXT
$547M
| $928K | ﹤0.01% |
208,087
| – | – |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.